ATA655474A - Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen, dispergierbaren pulvers - Google Patents

Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen, dispergierbaren pulvers

Info

Publication number
ATA655474A
ATA655474A AT655474A AT655474A ATA655474A AT A655474 A ATA655474 A AT A655474A AT 655474 A AT655474 A AT 655474A AT 655474 A AT655474 A AT 655474A AT A655474 A ATA655474 A AT A655474A
Authority
AT
Austria
Prior art keywords
manufacturing
dispersible powder
pharmaceutical
oral administrative
oral
Prior art date
Application number
AT655474A
Other languages
German (de)
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA655474A publication Critical patent/ATA655474A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT655474A 1973-08-13 1974-08-09 Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen, dispergierbaren pulvers ATA655474A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US387999A US3881005A (en) 1973-08-13 1973-08-13 Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof

Publications (1)

Publication Number Publication Date
ATA655474A true ATA655474A (de) 1977-02-15

Family

ID=23532208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT655474A ATA655474A (de) 1973-08-13 1974-08-09 Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen, dispergierbaren pulvers

Country Status (14)

Country Link
US (1) US3881005A (OSRAM)
JP (1) JPS5048115A (OSRAM)
AR (1) AR202034A1 (OSRAM)
AT (1) ATA655474A (OSRAM)
AU (1) AU7155674A (OSRAM)
BE (1) BE818729A (OSRAM)
DD (1) DD112899A5 (OSRAM)
DE (1) DE2437845A1 (OSRAM)
DK (1) DK427674A (OSRAM)
FR (1) FR2240717B1 (OSRAM)
IL (1) IL45311A0 (OSRAM)
NL (1) NL7410862A (OSRAM)
SE (1) SE7410331L (OSRAM)
ZA (1) ZA744587B (OSRAM)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
JPS5266616A (en) * 1975-11-29 1977-06-02 Sawai Seiyaku Kk Manufacturing of solidified oily liquid substance
WO1991001139A1 (de) * 1989-07-21 1991-02-07 Marigen S.A. Sterole, deren fettsäureester und glucoside; verfahren zu ihrer herstellung; spontan dispergierbare mittel mit diesen verbindungen, sowie ihre verwendung zur behandlung von tumoren
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
WO1995000158A1 (en) * 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US20030104035A1 (en) 1996-08-09 2003-06-05 Raisio Benecol Ltd. Stanol composition and the use thereof
FI105887B (fi) * 1996-09-27 2000-10-31 Suomen Sokeri Oy Elintarvike- ja terapeuttisiin sovelluksiin käyttökelpoiset, kasvisterolia sisältävät tuotteet, menetelmä niiden valmistamiseksi ja niiden käyttö
FI108110B (fi) * 1997-06-13 2001-11-30 Danisco Finland Oy Elintarvike- ja eläinravitsemusalalla käyttökelpoinen esiseos, menetelmä sen valmistamiseksi ja sen käyttö
US6423363B1 (en) † 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
IN185730B (OSRAM) * 1998-02-19 2001-04-14 Mcneil Ppc Inc
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
FR2775620B1 (fr) * 1998-03-05 2002-04-19 Gervais Danone Sa Suspension homogene stable depourvue d'emulsifiant, son procede de preparation et son utilisation dans des compositions alimentaires
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
US6123978A (en) 1998-08-31 2000-09-26 Mcneil-Ppc, Inc. Stable salad dressings
US6376481B2 (en) 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
US6242001B1 (en) 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
US6113972A (en) * 1998-12-03 2000-09-05 Monsanto Co. Phytosterol protein complex
EP1146798A2 (en) * 1999-01-15 2001-10-24 Nutrahealth Ltd. (UK) Modified food products and beverages, and additives for food and beverages
JP2002535975A (ja) * 1999-02-03 2002-10-29 フォーブス メディ−テック インコーポレーテッド フィトステロールまたはフィトスタノールの微粒子を製造する方法
US6190720B1 (en) * 1999-06-15 2001-02-20 Opta Food Ingredients, Inc. Dispersible sterol compositions
WO2001000046A1 (de) * 1999-06-25 2001-01-04 Cognis Deutschland Gmbh Verwendung von nanoskaligen sterolen und sterolestern
US6391370B1 (en) * 1999-11-12 2002-05-21 Kraft Foods, Inc. Micromilling plant sterols and emulsifiers
US6677327B1 (en) * 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
US6355274B1 (en) * 1999-12-15 2002-03-12 Mcneil-Ppc, Inc. Encapsulated long chain alcohols
US7232574B1 (en) 1999-12-15 2007-06-19 Mcneil-Ppc, Inc. Long chain alcohols provided in edible oils
GB0021498D0 (en) * 2000-09-01 2000-10-18 Novartis Nutrition Ag New formulation
AU2005234649B2 (en) * 2000-09-01 2008-01-17 Forbes Medi-Tech, Inc. Water-dispersible encapsulated sterols
US20030165572A1 (en) * 2000-09-01 2003-09-04 Nicolas Auriou Water-dispersible encapsulated sterols
KR20020026053A (ko) 2000-09-30 2002-04-06 노승권 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
ATE446013T1 (de) * 2001-11-16 2009-11-15 Univ Brandeis Fertignahrung, die aus triglyceriden umkristallisierte nichtveresterte phytosterole enthalten
US7144595B2 (en) * 2001-11-16 2006-12-05 Brandeis University Prepared foods containing triglyceride-recrystallized non-esterified phytosterols
FI117082B (fi) * 2002-02-08 2006-06-15 Raisio Yhtymae Oyj Esteröityjä kasvisteroleita sisältävä pastatuote
EP1653814A4 (en) * 2002-03-20 2009-03-04 Eugene Science Inc PLANT STARCH NUTRITIONAL AGENT AND METHOD FOR THE PRODUCTION THEREOF
US20050118203A1 (en) * 2002-03-20 2005-06-02 Won-Tae Yoon Mixing powder of plant sterol and emulsifier, and method for preparing the same
JP2005529109A (ja) * 2002-04-10 2005-09-29 カーギル，インコーポレイティド 水性分散性ステリル・エステル組成物
CA2488111A1 (en) * 2002-06-12 2003-12-24 The Coca-Cola Company Beverages containing plant sterols
US7732000B2 (en) * 2002-06-20 2010-06-08 General Mills, Inc. Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
ZA200600076B (en) 2003-07-17 2007-03-28 Unilever Plc Process for the preparation of an edible dispersion comprising oil and structuring agent
WO2005074717A1 (en) * 2004-01-30 2005-08-18 Unilever N.V. Particulate comprising phytosterols and food compositions comprising said creamer
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
US20050214383A1 (en) 2004-03-29 2005-09-29 William Bubnis Multi-vitamin and mineral nutritional supplements
US20060035009A1 (en) * 2004-08-10 2006-02-16 Kraft Foods Holdings, Inc. Compositions and processes for water-dispersible phytosterols and phytostanols
US20060034934A1 (en) * 2004-08-13 2006-02-16 Deguise Matthew L Agglomeration of sterol particles
CA2598401C (en) * 2005-02-17 2013-10-29 Unilever Plc Process for the preparation of a spreadable dispersion
DE102005008445A1 (de) * 2005-02-24 2006-08-31 Cognis Ip Management Gmbh Zuckerhaltige Sterolfeststoffdispersionen
DE102005039836A1 (de) * 2005-08-23 2007-03-01 Cognis Ip Management Gmbh Sterolesterpulver
US7575768B2 (en) * 2005-09-07 2009-08-18 Brandeis University Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols
US20070141123A1 (en) * 2005-12-20 2007-06-21 Forbes Medi-Tech Inc. Emulsions comprising non-esterified phytosterols in the aqueous phase
US8309156B2 (en) * 2005-12-20 2012-11-13 Pharmachem Laboratories, Inc. Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers
DE102006010663A1 (de) * 2006-03-08 2007-09-13 Cognis Ip Management Gmbh Verfahren zur Herstellung sterolhaltiger Pulver
EP1929884A1 (de) * 2006-12-04 2008-06-11 Cognis IP Management GmbH Verfahren zur Herstellung von Sterolformulierungen
US20090092727A1 (en) * 2007-10-04 2009-04-09 Daniel Perlman Water-dispersible phytosterol-surfactant conglomerate particles
US7790495B2 (en) * 2007-10-26 2010-09-07 International Business Machines Corporation Optoelectronic device with germanium photodetector
FI20085533A0 (fi) * 2008-06-02 2008-06-02 Raisio Nutrition Ltd Elintarvikekoostumus
US8273401B2 (en) * 2008-10-31 2012-09-25 Frito-Lay North America, Inc. Phytosterol/salt composition for topical application to food products
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
PL2367434T3 (pl) 2008-12-19 2017-09-29 Unilever BCS Europe B.V. Jadalne tłuszczowe proszki
US20110223312A1 (en) * 2009-11-30 2011-09-15 Daniel Perlman Triglyceride-encapsulated phytosterol microparticles dispersed in beverages
BR112012030147A2 (pt) 2010-06-22 2015-09-08 Unilever Nv "pó de gordura comestível, utilização do pó de gordura e processo para a preparação de um pó de gordura cometível
EP2651229B1 (en) 2010-12-17 2015-04-08 Unilever N.V. Edible water in oil emulsion
EP2651234B1 (en) 2010-12-17 2015-01-21 Unilever N.V. Process of compacting a microporous fat powder and compacted fat powder so obtained
TR201713347T1 (tr) 2015-03-11 2017-12-21 Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak Toplam ve LDL Kolesterol Seviyelerini Azaltmak için Polifenol İçeren Bitkisel Çaylarla Zenginleştirilmiş Sulu veya Toz Formda Suda Çözülebilir Sterol/Stanol
IT201700066508A1 (it) * 2017-06-15 2018-12-15 Isagro Spa Sospensioni concentrate di fitosteroli e relativo processo di preparazione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3800038A (en) * 1972-04-21 1974-03-26 Biolog Concepts Inc Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier

Also Published As

Publication number Publication date
AR202034A1 (es) 1975-05-09
SE7410331L (OSRAM) 1975-02-14
AU7155674A (en) 1976-01-29
DE2437845A1 (de) 1975-02-27
JPS5048115A (OSRAM) 1975-04-30
US3881005A (en) 1975-04-29
DK427674A (OSRAM) 1975-04-21
FR2240717A1 (OSRAM) 1975-03-14
IL45311A0 (en) 1974-10-22
NL7410862A (nl) 1975-02-17
BE818729A (fr) 1975-02-12
DD112899A5 (OSRAM) 1975-05-12
FR2240717B1 (OSRAM) 1977-11-04
ZA744587B (en) 1976-02-25

Similar Documents

Publication Publication Date Title
ATA655474A (de) Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen, dispergierbaren pulvers
NL7506407A (nl) Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
NL165651C (nl) Werkwijze ter bereiding van een oraal depotgeneesmiddel.
ATA6375A (de) Verfahren zur herstellung fester, oraler zubereitungen von schwerloslichen arzneimittelwirkstoffen
NL182369B (nl) Werkwijze voor het bereiden van een oraal geneesmiddelpreparaat met verlengde afgifte.
AT349150B (de) Verfahren zur herstellung pharmazeutischer pulver
NL7402689A (nl) Werkwijze ter bereiding van een oraal farma- ceutisch preparaat.
AT330360B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT346288B (de) Verfahren zur herstellung eines pulverfoermigen zeolithischen molekularsiebes des typs a
NL161462B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarvoor geschikte verbindingen.
AT337902B (de) Verfahren zur herstellung eines pharmazeutischen pulvers
AT330954B (de) Verfahren zur herstellung eines pharmazeutischen praparates
AT343802B (de) Verfahren zur herstellung von derivaten von 4,6-di-0- (aminoglycosyl)-2-deoxystreptaminen
AT341099B (de) Verfahren zur herstellung von oral zu applizierenden zubereitungsformen
AT339290B (de) Verfahren zur herstellung neueralpha-athyl-benzhydrol-derivate
NL187111B (nl) Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat op basis van 15,15-ethyleendioxyprostaanzuurderivaten met prostaglandinewerking, alsmede werkwijze ter bereiding van de hierbij te gebruiken 15,15-ethyleendioxyprostaanzuurderivaten.
IL46543A0 (en) New phenoxyalkyl-carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ATA756374A (de) Verfahren zur herstellung von 1- (4-amino-3,5-dihalogen-phenyl)-2-amino-athanolen-(1)
AT336176B (de) Verfahren zur herstellung eines pharmazeutischen praparates
NL187164C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat met anti-fertiliteitswerking, aldus verkregen gevormde preparaten, alsmede werkwijze ter bereiding van daarin toegepaste aroylfenylnaftaleenverbindingen.
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
AT309690B (de) Verfahren zur Herstellung einer verbesserten oralen Applikationsform von Raubasin
AT306047B (de) Verfahren zur Herstellung neuer 2,9-Dioxatricyclo(4,3,1,0<3,7>decan-4-one
ATA494176A (de) Verfahren zur herstellung eines mund- und zahnpflegemittels
AT312161B (de) Verfahren zur Herstellung eines pharmazeutischen Präparates

Legal Events

Date Code Title Description
A1Z Withdrawn